Search results
Crimean-Congo Hemorrhagic Fever Virus for Clinicians—Diagnosis, Clinical Management, and...
Centers for Disease Control and Prevention· 3 hours agoAlthough many laboratory assays have been developed for diagnosing CCHF, the availability and Biosafety Level (BSL) requirements for safe specimen handling vary widely between countries. Sweden ...
PFAS chemical levels prompt Kalispell to issue drinking water notice
KPAX Missoula· 5 hours agoTesting revealed that one of Kalispell's Public Water System wells has PFAS higher than the newly established limits set by the EPA.
Tumid lupus: Causes, symptoms, and treatment
Medical News Today· 4 days agoTumid lupus is a rare form of cutaneous lupus erythematosus. It causes a person to develop smooth, nonscarring pimples on their skin. Lupus is a chronic...
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the...
Morningstar· 10 hours agoThe contract period includes the base year ordering period of June 17, 2024 to June 16, 2025, as well as four one-year option periods that may be exercised unilaterally by the...
Checkpoint Inhibitors: A New Hope for Cancer Treatment
Forbes· 2 days agoThis article is part of an ongoing series on checkpoint inhibitors, a novel cancer immunotherapy....
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
Zacks via Yahoo Finance· 6 hours agoDanaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving...
4 Years In, a Sobering Look at Long COVID Progress
Medscape· 3 days agoFour years ago in the spring of 2020, physicians and patients coined the term "long COVID" to describe a form of the viral infection from which recovery...
WSU professor warns of fire blight antibiotic resistance
The Columbian· 5 hours agoFrank Zhao, a professor of plant pathology at Washington State University, spoke at the April 4 Fire Blight Webinar hosted by Michigan State University, providing an update ...
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update
ETF DAILY NEWS· 7 days agoVirax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling ...
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
FierceBiotech· 7 hours agoThe number of biopharma M&A deals more than doubled in the first quarter of 2024 compared to the...
